A RISK-BENEFIT ANALYSIS FOR THE TREATMENT OF HYPERTENSION

被引：4

作者：

BULPITT, CJ

机构：

[1] Division of Geriatric Medicine, Department of Medicine, Royal Postgraduate Medical School, London W12 0NN, Du Cane Road

来源：

关键词：

D O I：

10.1136/pgmj.69.816.764

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：764 / 774

页数：11

共 40 条

[1]

AMERY A, 1985, LANCET, V1, P1349

[2]

AMERY A, 1986, LANCET, V2, P589

[3]

AMERY A, 1990, HDB HYPERTENSION MAN, V13, P483

[4]

[Anonymous], 1985, J Hypertens, V3, P379

[5]

[Anonymous], 1991, Arch Intern Med, V151, P1413

[6]

[Anonymous], 1991, JAMA, V265, P3255

[7]

[Anonymous], 1982, NEW ENGL J MED, V307, P976

[8] MANAGEMENT OF ELDERLY PATIENTS WITH SUSTAINED HYPERTENSION [J].

BEARD, K ;

BULPITT, C ;

MASCIETAYLOR, H ;

OMALLEY, K ;

SEVER, P ;

WEBB, S .

BMJ-BRITISH MEDICAL JOURNAL, 1992, 304 (6824) :412-416

[9]

Bulpitt C J, 1992, Pharmacoeconomics, V1, P95, DOI 10.2165/00019053-199201020-00006

[10]

BULPITT CJ, 1992, J HYPERTENS, V10, pS45